Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Sovihep V (400 mg / 100 mg) is a prescription antiviral medication containing a fixed-dose combination of Sofosbuvir and Velpatasvir. It is primarily used in adults to treat all six major genotypes of chronic Hepatitis C virus (HCV) infection by preventing the virus from multiplying.
| Strength | 400/100 mg |
| Treatment | Treatment of Chronic Hepatitis C Virus (HCV) Infection |
| Shelf Life | 24 months |
| Packing | Bottles or packs of 28 tablets |
| Presciption status | Prescription-only medicine |
| Main Ingredients | Sofosbuvir 400 mg + Velpatasvir 100 mg |